OB/GYN
A 70-year-old woman presented with post-menopausal bleeding for the last 7 months.
Endometrial biopsy: Endometrial hyperplasia with atypia. She is unfit for surgery and anesthesia. Which of the following is the most appropriate alternative management?
Explanation
Core Concept: Management of atypical endometrial hyperplasia or early-stage, low-grade endometrial cancer in women who are medically inoperable or desire fertility preservation requires high-dose hormonal therapy to counteract estrogenic stimulation.
Clinical Presentation:
- Postmenopausal bleeding or abnormal perimenopausal bleeding
- Surgical contraindications (e.g., severe cardiopulmonary disease, extreme obesity)
- Complications: Disease progression if medical management fails.
Diagnosis:
- First-line: Endometrial biopsy confirming atypia.
- Gold Standard: Hysteroscopy with directed biopsy and pelvic MRI to evaluate the depth of myometrial invasion and rule out extrauterine spread before committing to medical management.
Management:
- Acute management: Optimize medical comorbidities and control bleeding.
- Long-term/definitive: Continuous high-dose progestin therapy (e.g., oral megestrol acetate, medroxyprogesterone acetate, or the LNG-IUS). Strict surveillance with endometrial sampling every 3-6 months is mandatory. If the patient becomes a surgical candidate or if the disease progresses, hysterectomy is indicated.